Portfolio

ALGIAX

Algiax Pharmaceuticals is a young, innovative research company in the field of neurological diseases with a special focus on neuropathic pain.

Management

Stefan Fischer

Pressemeldungen

High-Tech Gründerfonds, Private Investors and KfW invest €4.3 million in Algiax Pharmaceuticals GmbH

Advanced Therapy for Neuropathic Pain Algiax Pharmaceuticals GmbH, headquartered in Erkrath, is a biotechnology research company which was founded in July 2011. It is dedicated to drug development addressing central nervous system (CNS) illnesses and dysfunctions, with a focus on neuropathic pain. A consortium of…
Read

Info & Contact

Jürgen Schumacher
Web:
www.algiax.com

Address

Max-Planck-Straße 15a
40699 Erkrath

In portfolio

13. Jan 2012